Clinical Trial Update: Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies [Phase 1]

View source ↗

Summary

A Phase 1 exploratory trial evaluating delivery of LMN-201 components via enteric capsules in ostomy patients with Clostridioides difficile infection. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• LMN-201

Snippet

Sponsor: Lumen Bioscience, Inc. | Conditions: C. Diff. Infections | Phase 1 | Status: COMPLETED | Results posted: 2025-03-18